ONLINE DATABASE SEARCH - HIV-LS-310-MEMO
1. 44412 HIV-LS-310; PUBMED-HIV-11/30/2004
Negative feedback inhibition of HIV-1 by TAT-inducible expression of siRNA
Unwalla, HJ, Li, MJ, Kim, JD, Li, HT, Ehsani, A, Alluin, J, and Rossi, JJ
Nat Biotechnol 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15568018&dopt=abstract
2. 44413 HIV-LS-310; PUBMED-HIV-11/30/2004
The effect of iron overload on in vitro HIV-1 infection
Traore, HN and Meyer, D
J Clin Virol 2004. 31 Suppl 1: 92-8
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15567100&dopt=abstract
3. 44414 HIV-LS-310; EMBASE-HIV-11/30/2004
Fixed Conformation Nucleoside Analogs Effectively Inhibit Excision-proficient HIV-1 Reverse Transcriptases
Boyer, Paul L, Julias, John G, Marquez, Victor E, and Hughes, Stephen H
Journal of Molecular Biology 2004. In Press, Corrected Proof
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WK7-4DTKYCJ-2/2/1bdea11a69c17f276841437d6eb0b74c
4. 44415 HIV-LS-310; PUBMED-HIV-11/30/2004
TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1
Andries, K, Azijn, H, Thielemans, T, Ludovici, D, Kukla, M, Heeres, J, Janssen, P, De, Corte B, Vingerhoets, J, Pauwels, R, and de, Bethune MP
Antimicrob Agents Chemother 2004. 48(12): 4680-6
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15561844&dopt=abstract
5. 44416 HIV-LS-310; PUBMED-HIV-11/30/2004
Gln145Met/Leu Changes in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confer Resistance to Nucleoside and Nonnucleoside Analogs and Impair Virus Replication
Paolucci, S, Baldanti, F, Maga, G, Cancio, R, Zazzi, M, Zavattoni, M, Chiesa, A, Spadari, S, and Gerna, G
Antimicrob Agents Chemother 2004. 48(12): 4611-7
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15561833&dopt=abstract
6. 44417 HIV-LS-310; PUBMED-HIV-11/30/2004
Globoidnan A: a lignan from Eucalyptus globoidea inhibits HIV integrase
Ovenden, SP, Yu, J, San, Wan S, Sberna, G, Murray, Tait R, Rhodes, D, Cox, S, Coates, J, Walsh, NG, and Meurer-Grimes, BM
Phytochemistry 2004. 65(24): 3255-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15561191&dopt=abstract
7. 44418 HIV-LS-310; PUBMED-HIV-11/30/2004
Symmetric fluoro-substituted diol-based HIV protease inhibitors
Lindberg, J, Pyring, D, Lowgren, S, Rosenquist, A, Zuccarello, G, Kvarnstrom, I, Zhang, H, Vrang, L, Classon, B, Hallberg, A, Samuelsson, B, and Unge, T
Eur J Biochem 2004. 271(22): 4594-602
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15560801&dopt=abstract
8. 44419 HIV-LS-310; PUBMED-HIV-11/30/2004
Role of hydroxyl group and R/S configuration of isostere in binding properties of HIV-1 protease inhibitors
Petrokova, H, Duskova, J, Dohnalek, J, Skalova, T, Vondrackova-Buchtelova, E, Soucek, M, Konvalinka, J, Brynda, J, Fabry, M, Sedlacek, J, and Hasek, J
Eur J Biochem 2004. 271(22): 4451-61
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15560786&dopt=abstract
9. 44420 HIV-LS-310; PUBMED-HIV-11/30/2004
Optimization of unique, uncharged thioesters as inhibitors of HIV replication
Srivastava, P, Schito, M, Fattah, RJ, Hara, T, Hartman, T, Buckheit, RW Jr, Turpin, JA, Inman, JK, and Appella, E
Bioorg Med Chem 2004. 12(24): 6437-50
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15556761&dopt=abstract
10. 44421 HIV-LS-310; PUBMED-HIV-11/30/2004
QSAR modeling of anti-HIV activities of alkenyldiarylmethanes using topological and physicochemical descriptors
Leonard, JT and Roy, K
Drug Des Discov 2003. 18(4): 165-80
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15553927&dopt=abstract
11. 44422 HIV-LS-310; PUBMED-HIV-11/30/2004
HIV-1 reverse transcriptase variants: molecular modeling of Y181C, V106A, L100I, and K103N mutations with nonnucleoside inhibitors using Monte Carlo simulations in combination with a linear response method
Smith, MB, Ruby, S, Horouzhenko, S, Buckingham, B, Richardson, J, Puleri, I, Potts, E, Jorgensen, WL, Arnold, E, Zhang, W, Hughes, SH, Michejda, CJ, and Smith, RH Jr
Drug Des Discov 2003. 18(4): 151-63
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15553926&dopt=abstract
12. 44423 HIV-LS-310; PUBMED-HIV-11/30/2004
Effect of highly active antiretroviral therapy (HAART) on pharmacokinetics and pharmacodynamics of doxorubicin in patients with HIV-associated non-Hodgkin's lymphoma
Toffoli, G, Corona, G, Cattarossi, G, Boiocchi, M, Di, Gennaro G, Tirelli, U, and Vaccher, E
Ann Oncol 2004. 15(12): 1805-9
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15550586&dopt=abstract
13. 44424 HIV-LS-310; PUBMED-HIV-11/30/2004
Mechanistic insights into the suppression of drug-resistance by human immunodeficiency virus type-1 reverse transcriptase using alpha-boranophosphate nucleoside analogues
Deval, J, Alvarez, K, Selmi, B, Bermond, M, Boretto, J, Guerreiro, C, Mulard, L, and Canard, B
J Biol Chem 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15550379&dopt=abstract
14. 44425 HIV-LS-310; PUBMED-HIV-11/30/2004
Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus
Wang, Q, Ding, ZH, Liu, JK, and Zheng, YT
Antiviral Res 2004. 64(3): 189-94
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15550272&dopt=abstract
15. 44426 HIV-LS-310; PUBMED-HIV-11/30/2004
Antiretrovirals, Part II: focus on non-protease inhibitor antiretrovirals (NRTIs, NNRTIs, and fusion inhibitors)
Zapor, MJ, Cozza, KL, Wynn, GH, Wortmann, GW, and Armstrong, SC
Psychosomatics 2004. 45(6): 524-35
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15546830&dopt=abstract
16. 44427 HIV-LS-310; PUBMED-HIV-11/30/2004
QSAR modelling of HIV-1 reverse transcriptase inhibition by benzoxazinones using a combination of P_VSA and pharmacophore feature descriptors
Balaji, S, Karthikeyan, C, Hari, Narayana Moorthy NS, and Trivedi, P
Bioorg Med Chem Lett 2004. 14(24): 6089-94
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15546736&dopt=abstract
17. 44428 HIV-LS-310; PUBMED-HIV-11/30/2004
Synthesis of Poly(ethylene glycol)-Based Saquinavir Prodrug Conjugates and Assessment of Release and Anti-HIV-1 Bioactivity Using a Novel Protease Inhibition Assay
Gunaseelan, S, Debrah, O, Wan, L, Leibowitz, MJ, Rabson, AB, Stein, S, and Sinko, PJ
Bioconjug Chem 2004. 15(6): 1322-1333
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15546199&dopt=abstract
18. 44429 HIV-LS-310; PUBMED-HIV-11/30/2004
Discovery, structure and biological activities of the cyclotides
Craik, DJ, Daly, NL, Mulvenna, J, Plan, MR, and Trabi, M
Curr Protein Pept Sci 2004. 5(5): 297-315
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15544527&dopt=abstract
19. 44430 HIV-LS-310; PUBMED-HIV-11/30/2004
Target cell cyclophilin a modulates human immunodeficiency virus type 1 infectivity
Sokolskaja, E, Sayah, DM, and Luban, J
J Virol 2004. 78(23): 12800-8
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15542632&dopt=abstract
20. 44431 HIV-LS-310; PUBMED-HIV-11/30/2004
Analysis of HIV-1 Vif-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization
Wichroski, MJ, Ichiyama, K, and Rana, T
J Biol Chem 2004.
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15537645&dopt=abstract
21. 44432 HIV-LS-310; EMBASE-HIV-11/30/2004
HIV resistance to the fusion inhibitor enfuvirtide: mechanisms and clinical implications
Miller, Michael D and Hazuda, Daria J
Drug Resistance Updates 2004. 7(2): 89-95
HYPERLINK:
http://www.sciencedirect.com/science/article/B6WDK-4CBW4T9-2/2/d5ce69cecfcfa3a1805266d8bd9c31d4
22. 44433 HIV-LS-310; PUBMED-HIV-11/30/2004
Flexible docking of pyridinone derivatives into the non-nucleoside inhibitor binding site of HIV-1 reverse transcriptase
Medina-Franco, JL, Rodriguez-Morales, S, Juarez-Gordiano, C, Hernandez-Campos, A, Jimenez-Barbero, J, and Castillo, R
Bioorg Med Chem 2004. 12(23): 6085-6095
HYPERLINK:
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15519154&dopt=abstract
23. 44434 HIV-LS-310; WOS-HIV-11/21/2004
Flipping the switch from monomeric to dimeric CV-N has little effect on antiviral activity
Barrientos, LG, Lasala, F, Delgado, R, Sanchez, A, and Gronenborn, AM
STRUCTURE 2004. 12(10): 1799-1807, 9
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224540800007
24. 44435 HIV-LS-310; WOS-HIV-11/21/2004
In vitro antiviral diterpenes from the Brazilian brown alga Dictyota pfaffii
Barbosa, JP, Pereira, RC, Abrantes, JL, dos, Santos CCC, Rebello, MA, Frugulhetti, ICDP, and Teixeira, VL
PLANTA MEDICA 2004. 70(9): 856-860, 5
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224440700014
25. 44436 HIV-LS-310; WOS-HIV-11/21/2004
Correlation between the predicted and the observed biological activity of the symmetric and nonsymmetric cyclic urea derivatives used as HIV-1 protease inhibitors. A 3D-QSAR-CoMFA method for new antiviral drug design
Avram, S, Svab, I, Bologa, C, and Flonta, ML
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE 2003. 7(3): 287-296, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224538000010
26. 44437 HIV-LS-310; WOS-HIV-11/21/2004
Three new compounds from the plant Lippia alva as inhibitors of chemokine receptor 5 (CCRS)
Hegde, VR, Pu, HY, Patel, M, Das, PR, Strizki, J, Gullo, VP, Chou, CC, Buevich, AV, and Chan, TM
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 2004. 14(21): 5339-5342, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224446600019
27. 44438 HIV-LS-310; WOS-HIV-11/28/2004
Differential effects on human immunodeficiency virus type 1 replication by alpha-defensins with comparable bactericidal activities
Tanabe, H, Ouellette, AJ, Cocco, MJ, and Robinson, WE
JOURNAL OF VIROLOGY 2004. 78(21): 11622-11631, 10
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224540900016
28. 44439 HIV-LS-310; WOS-HIV-11/28/2004
Lv1 inhibition of human immunodeficiency virus type 1 is counteracted by factors that stimulate synthesis or nuclear translocation of viral cDNA
Berthoux, L, Sebastian, S, Sokolskaja, E, and Luban, J
JOURNAL OF VIROLOGY 2004. 78(21): 11739-11750, 12
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224540900028
29. 44440 HIV-LS-310; WOS-HIV-11/28/2004
Amino acid insertions near gag cleavage sites restore the otherwise compromised replication of human immunodeficiency virus type 1 variants resistant to protease inhibitors
Tamiya, S, Mardy, S, Kavlick, MF, Yoshimura, K, and Mistuya, H
JOURNAL OF VIROLOGY 2004. 78(21): 12030-12040, 11
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224540900055
30. 44441 HIV-LS-310; WOS-HIV-11/28/2004
The ability of chloroquine to prevent Tat-induced cytokine secretion by monocytes is implicated in its in vivo anti-human immunodeficiency virus type 1 activity
Rayne, F, Vendeville, A, Bonhoure, A, and Beaumelle, B
JOURNAL OF VIROLOGY 2004. 78(21): 12054-12057, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224540900058
31. 44442 HIV-LS-310; WOS-HIV-11/28/2004
APOBEC3G incorporation into human immunodeficiency virus type 1 particles
Zennou, W, Perez-Caballero, D, Gottlinger, H, and Bieniasz, PD
JOURNAL OF VIROLOGY 2004. 78(21): 12058-12061, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224540900059
32. 44443 HIV-LS-310; WOS-HIV-11/28/2004
Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1
Giguere, JF and Tremblay, MJ
JOURNAL OF VIROLOGY 2004. 78(21): 12062-12065, 4
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000224540900060